Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Lithium naphthenate consists of lithium salts of naphthenic acids and is expected to dissociate in the human body to lithium cations and naphthenic acid anions. Therefore, data are presented to address the lithium cations and naphthenic acid anions separately. No human data are available for naphthenic acids. Significant published evidence is available from human exposure to lithium cations. Data on the human serum lithium ion concentration are provided in the Repeated Dose Toxicity Endpoint section.

Additional information

The lithium cation has been used extensively in human therapy for bipolar disease for example, in the form of lithium salts (e.g. carbonate, acetate, sulphate). As a result, considerable information is available on safe serum lithium ion concentrations over long periods of administration. To determine the hazard associated with the lithium ion from lithium naphthenate, it is appropriate to use the human serum lithium ion concentration, converted to equivalent lithium naphthenate concentration.